MONDAY, Oct. 30, 2023 (HealthDay News) — Patients with sickle cell disease may soon have two new treatments to try. On Tuesday, a U.S. Food and Drug Administration advisory committee will weigh the merits of a new gene therapy for the painful, inherited condition, which typically strikes Black people. The agencyContinue Reading

MONDAY, Oct. 30, 2023 (HealthDay News) — Kids with a genetic risk for autism spectrum disorder (ASD) are likely to spend hours a day glued to their screens, but researchers say it doesn’t mean screen time causes ASD. The investigators also found that children with attention-deficit/hyperactivity disorder (ADHD) gradually increasedContinue Reading